News - Financial

Filter

Current filters:

Financial

Popular Filters

120 to 144 of 1447 results

NHS England approves GSK’s Tafinlar for funding by UK’s Cancer Drugs Fund

NHS England approves GSK’s Tafinlar for funding by UK’s Cancer Drugs Fund

04-02-2014

GlaxoSmithKline’s Tafinlar (dabrafenib) is now available for metastatic melanoma patients in England…

FinancialGSKOncologyPharmaceuticalRegulationTafinlarUK

PDL BioPharma settles litigation with Genentech and Roche

03-02-2014

US drugmaker PDL BioPharma has entered into an agreement with Genentech and its parent, Swiss drug major…

BiotechnologyFinancialGenentechLegalOncologyOphthalmicsPDL BioPharmaRoche

Pharma multinationals facing more pricing problems in India

Pharma multinationals facing more pricing problems in India

03-02-2014

Even as a battle royal appears to be brewing between India's drug price regulator, the National Pharma…

Asia-PacificAstraZenecaFinancialGlaxoSmithKlineIndiaNovartisPfizerPharmaceuticalPricing

AbbVie sees profits downturn but meets analysts’ expectations

AbbVie sees profits downturn but meets analysts’ expectations

01-02-2014

US drugmaker AbbVie’s shares gained 3% to $49.77 in morning trading on January 31, when the company…

AbbVieFinancialPharmaceutical

Actavis refocuses global business structure; reiterates 2014 outlook

Actavis refocuses global business structure; reiterates 2014 outlook

01-02-2014

US generics major Actavis, which now has its headquarters in Ireland, has announced a realignment of…

ActavisBoardroomFinancialGenerics

Celgene profits hit by higher R&D, acquisition costs

Celgene profits hit by higher R&D, acquisition costs

31-01-2014

US biotech major Celgene reported financial results for the fourth-quarter and full-year 2013, with final…

BiotechnologyCelgeneFinancial

Medigene’s buy of Trianta is “lucrative move” say analysts

31-01-2014

Medigene’s 4 million euro ($5.5 million) purchase of fellow German company Trianta Immunotherapies…

FinancialImmunologicalsMedigeneMergers & AcquisitionsOncologyPharmaceuticalTrianta ImmunotherapiesUSA

Eli Lilly sales beat forecasts, despite 2% decline

Eli Lilly sales beat forecasts, despite 2% decline

30-01-2014

US pharma major Eli Lilly has reported financial results, showing that global sales in the fourth quarter…

Eli LillyFinancialPharmaceutical

Viralytics reveals “transformational” A$27 million capital raising

30-01-2014

Australia’s Viralytics is undertaking a transformational capital raising of up to A$27.1 million ($23.6)…

CavatakFinancialOncologyPharmaceuticalResearchViralytics

Hutchison China MediTech upgraded by Panmure

30-01-2014

In a new report on Chinese pharmaceutical company Hutchison China MediTech, Panmure Gordon analyst Savvas…

AstraZenecaFinancialHutchison MediTechOncologyPharmaceuticalResearchvolitinib

Novo Nordisk’s profits rise 15% with further growth expected

Novo Nordisk’s profits rise 15% with further growth expected

30-01-2014

Danish insulin giant Novo Nordisk has announced a 15% growth in profit in the firm’s 2013 financial…

DenmarkDiabetesFinancialNovo NordiskPharmaceuticalTresibaVictoza

Roche sees strong 2013 sales growth, but still disappoints

Roche sees strong 2013 sales growth, but still disappoints

30-01-2014

Swiss drug major Roche posted full-year 2013 financial results this morning, showing that group sales…

FinancialRoche

Biogen Idec beats on sales and earnings, with shinning performance from Tecfidera

Biogen Idec beats on sales and earnings, with shinning performance from Tecfidera

29-01-2014

US biotech firm Biogen Idec reported full year and fourth quarter 2013 results that beat consensus Wall…

Biogen IdecBiotechnologyFinancialTecfidera

Novartis delivers strong sales, despite generic erosion, but misses expectations

Novartis delivers strong sales, despite generic erosion, but misses expectations

29-01-2014

Swiss drug major Novartis this morning reported that fourth-quarter net income rose 2% to $2.06 billion,…

FinancialNovartisPharmaceutical

Pfizer shares gain despite lower sales and profits

Pfizer shares gain despite lower sales and profits

29-01-2014

US pharma giant Pfizer reported fourth-quarter and full-year 2013 financial results that beat consensus…

FinancialPfizerPharmaceutical

Amgen again tops analysts’ forecasts as profits rise 30%

Amgen again tops analysts’ forecasts as profits rise 30%

29-01-2014

Amgen, the world’s largest independent biotech firm, for the fifth reporting quarter beat analysts’…

AmgenBiotechnologyFinancial

Ipsen’s sales grow 2.2% in 2013, but miss expectations

Ipsen’s sales grow 2.2% in 2013, but miss expectations

28-01-2014

French drugmaker Ipsen posted solid sales growth for fourth-quarter and full-year 2013, though there…

FinancialIpsenPharmaceutical

Cadila pulls out of operations in Japan

Cadila pulls out of operations in Japan

28-01-2014

One of India’s largest pharmaceutical companies, Cadila Healthcare (also operating as Zydus Cadila),…

Asia-PacificFinancialIndiaPharmaceuticalZydus Cadila

European Parliament ITRE committee passes milestone on the path to implementing IMI2

28-01-2014

The European Parliament's committee on industry, research and energy (ITRE) on January 24 adopted the…

EuropeFinancialPharmaceuticalPoliticsResearch

Ipsen, a good European mid-cap to watch, says US analyst

Ipsen, a good European mid-cap to watch, says US analyst

27-01-2014

Most American investors are familiar with large European drugmakers like Sanofi and Novartis but the…

FinancialIpsenOncologyPharmaceuticalResearchSomatulinetasquinimod

Call for strategic regulatory rethink for EU generic medicines industry

Call for strategic regulatory rethink for EU generic medicines industry

27-01-2014

“It is vital that costs associated with regulatory processes do not become a barrier to developing…

EuropeFinancialGenericsRegulation

10 billion real to be invested in Brazil’s production of biotech drugs by 2016

10 billion real to be invested in Brazil’s production of biotech drugs by 2016

27-01-2014

Brazil's Development Bank (BNDS) plans to invest up to 10 billion real ($4.2 billion) in the production…

BiotechnologyBrazilFinancialGenericsHypermarcasMarkets & MarketingProductionSanofiSouth America

Bristol-Myers Squibb beats forecasts, helped by strong product growth

Bristol-Myers Squibb beats forecasts, helped by strong product growth

24-01-2014

US pharma major Bristol-Myers Squibb presented fourth-quarter and full-year 2013 financial results, which…

Bristol-Myers SquibbFinancialPharmaceutical

Prothena to get $30 million upfront from Roche triggered by regulatory milestone

Prothena to get $30 million upfront from Roche triggered by regulatory milestone

23-01-2014

Clinical-stage biotech firm Prothena said today that it will receive the $30 million upfront payment…

BiotechnologyFinancialLicensingNeurologicalProthenaPRX002Roche

120 to 144 of 1447 results

Back to top